Pneumatocele during sorafenib therapy: first report of an unusual complication

Oncotarget
Paloma SangroBruno Sangro

Abstract

Sorafenib is a multi-kinase inhibitor and a vascular endothelial growth factor (VEGF) inhibitor approved to treat patients with advanced hepatocellular carcinoma, renal cell carcinoma and differentiated thyroid carcinoma. Its most common side effects are asthenia/fatigue, skin toxicity, diarrhea and arterial hypertension. Reported respiratory adverse reactions include dyspnea, cough, pleural effusion and hoarseness. The aim of this report is to describe for the first time the occurrence of pneumatocele in two patients treated with Sorafenib. Patients had no respiratory symptoms and alternative diagnoses were ruled out. Primary tumors were different (liver metastases from a pancreatic neuroendocrine tumor and hepatocellular carcinoma) but both patients had been treated with yttrium 90 radioembolization 9 and 17 months before starting on Sorafenib, respectively. No complications occurred and Sorafenib withdrawal was followed by radiologic improvement.

References

Jun 1, 1988·AJR. American Journal of Roentgenology·M J Quigley, R S Fraser
Aug 1, 1972·The Journal of Pediatrics·G F Boisset
Apr 1, 1996·European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [et Al] = Zeitschrift Für Kinderchirurgie·G Schimpl, U Schneider
Jan 15, 2002·The Journal of Biological Chemistry·Cong YanOkyanus Gurel
Jan 1, 2004·The Journal of Clinical Investigation·Isamu HokutoJeffrey A Whitsett
Sep 21, 2007·The New England Journal of Medicine·Steven M HollandBodo Grimbacher
Apr 26, 2008·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Suhail Al-SalehPeter Cox
May 31, 2008·Digestive Diseases and Sciences·Jorge-Shmuel DelgadoMarc Bissonnette
Feb 5, 2009·Pediatric Research·Alexandra F Freeman, Steven M Holland
Oct 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Boris R A BlechaczGregory J Gores
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Oct 26, 2011·World Journal of Gastroenterology : WJG·Fang-Ming GuJian Zhou
Apr 25, 2012·Journal of Vascular and Interventional Radiology : JVIR·Chadwick L WrightRiad Salem
Jul 4, 2012·International Journal of Clinical Oncology·Yuka Horiuchi-YamamotoShoji Kudoh

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
X-ray

Software Mentioned

TARE

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Related Papers

The New England Journal of Medicine
Josep M LlovetSHARP Investigators Study Group
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Luigi Bolondi, Fabio Piscaglia
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Seung Kak ShinJu Hyun Kim
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Ian A Rowe
Dermatology Online Journal
L CuestaA Monteagudo
© 2022 Meta ULC. All rights reserved